Top in hem/onc: Biden’s tax proposals, updated lung cancer screening guidance

The top story in hematology/oncology last week was a comprehensive review of what President Joe Biden’s tax proposals could mean for physicians.

Another top story focused on new lung cancer screening guidance that was recently finalized by the U.S. Preventive Services Task Force. The recommendations are an update from the task force’s 2013 guidance.

Read these and more top stories in hematology/oncology below:

What physicians should know about Biden’s tax proposals

With the Democrats controlling both houses of Congress, there is a likelihood that Biden’s tax proposals may pass this year. Read more.

Task force: Start lung cancer screening at age 50 years, 20 pack-years of smoking

The U.S. Preventive Services Task Force issued its final guidance on lung cancer screening, lowering the age to start screening to 50 years and the required smoking history to 20 pack-years. Read more.

FDA grants fast track designation to stem cell therapy for type 1 diabetes

The FDA granted fast track designation to VX-880 (Vertex Pharmaceuticals), a human stem cell-derived therapy for patients with type 1 diabetes, according to the agent’s manufacturer. Read more.

High cadmium intake linked to shorter OS among women with endometrial cancer

High daily dietary cadmium intake appeared to be associated with shorter overall survival among women with endometrial cancer, according to study results published in Nutrition and Cancer. Read more.

Weight loss linked to poorer survival outcomes in HER2-positive early breast cancer

Weight loss after diagnosis of HER2-positive early breast cancer appeared to be associated with poorer survival outcomes, according to study results published in Journal of the National Comprehensive Cancer Network. Read more.